Skip to Main Content

Author Details

Robert M Califf
From the National Institutes of Health
1978
1360
176
PMIDPaper TitleJournal TitlePublished Year
36701600Our National Approach to Diabetes.Diabetes Care2023
36647919Now is the time to fix the evidence generation system.Clin Trials2023
36701600Our National Approach to Diabetes.Diabetes Care2023
37450514Challenges in the Ethics and Implementation of Learning Health Care Systems.Am J Bioeth2023
36696486Biological therapies need definitive randomized controlled clinical trials.Sci Transl Med2023
37306505Testing for Fentanyl - Urgent Need for Practice-Relevant and Public Health Research.N Engl J Med2023
37039793Over-the-counter Hearing Aids-Reply.JAMA2023
37450514Challenges in the Ethics and Implementation of Learning Health Care Systems.Am J Bioeth2023
37039793Over-the-counter Hearing Aids-Reply.JAMA2023
37306505Testing for Fentanyl - Urgent Need for Practice-Relevant and Public Health Research.N Engl J Med2023
36696486Biological therapies need definitive randomized controlled clinical trials.Sci Transl Med2023
36647919Now is the time to fix the evidence generation system.Clin Trials2023
34797725Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.Circulation2022
36031002General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity.J Affect Disord2022
35499853COVID-19 Vaccination-Becoming Part of the New Normal.JAMA2022
36279126Benefits of Streamlined Point-of-Care Trial Designs: Lessons Learned From the UK RECOVERY Study.JAMA Intern Med2022
35872137Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study.J Cardiovasc Comput Tomogr2022
36459164Over-the-counter Hearing Aids: From Research to Policy to Practice.JAMA2022
33895994When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?Clin Pharmacol Ther2022
33829639When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?Clin Pharmacol Ther2022
33932030When Can We Trust Real-World Data To Evaluate New Medical Treatments?Clin Pharmacol Ther2022
33826756When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?Clin Pharmacol Ther2022
34797725Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial.Circulation2022
34405346Importance of Social Determinants in Screening for Depression.J Gen Intern Med2022
35333502Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.Cancer J2022
34656074Roadmap to 2030 for Drug Evaluation in Older Adults.Clin Pharmacol Ther2022
34752906The Ecosystem to Support People With Heart Failure.J Card Fail2022
35499853COVID-19 Vaccination-Becoming Part of the New Normal.JAMA2022
36459164Over-the-counter Hearing Aids: From Research to Policy to Practice.JAMA2022
35872137Association of left ventricular diastolic function with coronary artery calcium score: A Project Baseline Health Study.J Cardiovasc Comput Tomogr2022
36279126Benefits of Streamlined Point-of-Care Trial Designs: Lessons Learned From the UK RECOVERY Study.JAMA Intern Med2022
36031002General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity.J Affect Disord2022
33829639When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?Clin Pharmacol Ther2022
33826756When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?Clin Pharmacol Ther2022
33895994When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?Clin Pharmacol Ther2022
33932030When Can We Trust Real-World Data To Evaluate New Medical Treatments?Clin Pharmacol Ther2022
35333502Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress.Cancer J2022
34405346Importance of Social Determinants in Screening for Depression.J Gen Intern Med2022
34752906The Ecosystem to Support People With Heart Failure.J Card Fail2022
34656074Roadmap to 2030 for Drug Evaluation in Older Adults.Clin Pharmacol Ther2022
32968225The failure to fail smartly.Nat Rev Drug Discov2021
36713597Mapping and quantification of the twitter footprint of cardiologists.Eur Heart J Digit Health2021
34169139Life expectancy and voting patterns in the 2020 U.S. presidential election.SSM Popul Health2021
33847746A call to action for new global approaches to cardiovascular disease drug solutions.Eur Heart J2021
33847047Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE-MI): design and baseline characteristics.Eur J Heart Fail2021
33578196Corrigendum to "Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example" [Contemporary Clinical Trials volume 88 (2020) 105775].Contemp Clin Trials2021
34100876Rural-Urban Disparity in Mortality in the US From 1999 to 2019.JAMA2021
33876947A Call to Action for New Global Approaches to Cardiovascular Disease Drug Solutions.Circulation2021
34028521Trial Reporting and the Clinical Trials Enterprise.JAMA Intern Med2021
33820441Avoiding the Coming Tsunami of Common, Chronic Disease: What the Lessons of the COVID-19 Pandemic Can Teach Us.Circulation2021
  • 1 - 50 of 2,720

Recommended Authors

Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2014
Number of shared co-authors 8
Comparative Effective Research Institute, Lahey Hospital and Medical Center
Career Start Year 2013
Number of shared co-authors 4
AIG Hospitals Institute of Cardiac Sciences and Research
Career Start Year 2011
Number of shared co-authors 0
Yale/YNHH Center for Outcomes Research and Evaluation (CORE)
Career Start Year 2008
Number of shared co-authors 11
New York University Grossman School of Medicine
Career Start Year 2004
Number of shared co-authors 31
Washington University School of Medicine
Career Start Year 2004
Number of shared co-authors 39
Beth Israel Deaconess Medical Center
Career Start Year 2000
Number of shared co-authors 20
St Luke's Mid America Heart Institute
Career Start Year 1999
Number of shared co-authors 28
University of Alberta
Career Start Year 1999
Number of shared co-authors 7
Beth Israel Deaconess Medical Center
Career Start Year 1998
Number of shared co-authors 41
Brigham and Women's Hospital
Career Start Year 1998
Number of shared co-authors 25
Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 24
Atlanta VA Healthcare System
Career Start Year 1997
Number of shared co-authors 10
Division of Cardiology University of Texas Southwestern Medical Center Dallas TX USA.
Career Start Year 1996
Number of shared co-authors 6
University of Florida
Career Start Year 1995
Number of shared co-authors 16
University of Colorado School of Medicine
Career Start Year 1994
Number of shared co-authors 65
University of Missouri-Kansas City School of Medicine
Career Start Year 1994
Number of shared co-authors 93
Oregon Health and Science University
Career Start Year 1991
Number of shared co-authors 24
University of Florida
Career Start Year 1991
Number of shared co-authors 2
Vanderbilt University Medical Center
Career Start Year 1991
Number of shared co-authors 13
Beth Israel Deaconess Medical Center
Career Start Year 1990
Number of shared co-authors 23
Stanford University School of Medicine
Career Start Year 1989
Number of shared co-authors 68
Mayo Clinic
Career Start Year 1989
Number of shared co-authors 16
California Pacific Medical Center
Career Start Year 1984
Number of shared co-authors 25
Mayo Clinic
Career Start Year 1983
Number of shared co-authors 9
University of Pennsylvania Perelman School of Medicine
Career Start Year 1982
Number of shared co-authors 8
New York University School of Medicine
Career Start Year 1979
Number of shared co-authors 37
University of Milano
Career Start Year 1979
Number of shared co-authors 38
MedStar Health Research Institute and Georgetown University
Career Start Year 1979
Number of shared co-authors 60
Dartmouth-Hitchcock Medical Center
Career Start Year 1976
Number of shared co-authors 32

Collaborators

Universidade Federal de Sao Paulo
Co-authored papers 319
Co-authored papers 175
Co-authored papers 113
Duke University Medical Center-Duke Clinical Research Institute
Co-authored papers 111
Stanford University Medical School
Co-authored papers 110
University of Texas Southwestern Medical Center
Co-authored papers 90
Vanderbilt University School of Medicine
Co-authored papers 56
Yale School of Medicine
Co-authored papers 51
Co-authored papers 50
Duke University Medical Center
Co-authored papers 46
Duke University
Co-authored papers 46
Duke University Medical Center
Co-authored papers 42
Co-authored papers 42
Co-authored papers 41
Duke Clinical Research Institute
Co-authored papers 37
Co-authored papers 36
Duke Clinical Research Institute, Duke University
Co-authored papers 35
Duke University, NC Duke Clinical Research Institute
Co-authored papers 35
Co-authored papers 32
Duke Clinical Research Institute, Duke University
Co-authored papers 29
Clinical Epidemiology Unit, Massachusetts General Hospital
Co-authored papers 29
Icahn School of Medicine at Mount Sinai Health System
Co-authored papers 20
Brigham and Women's Hospital
Co-authored papers 19
Duke Clinical Research Institute
Co-authored papers 18
Duke University
Co-authored papers 16
Brody School of Medicine, East Carolina University
Co-authored papers 16
Bluhm Cardiovascular Institute, Northwestern University Feingerg School of Medicine
Co-authored papers 16
University of Maryland School of Medicine, University of Maryland
Co-authored papers 14
Harvard Medical School Center for Primary Care
Co-authored papers 14
FibroGen Inc.
Co-authored papers 14